X

KPTI

Karyopharm Therapeutics Inc Shares Rise After Q4 2025 Results

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Shares closed at $6.31 on the Nasdaq in the most recent session, reflecting an intraday…

Karyopharm Therapeutics Inc (KPTI) Q2 2022

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q2 2022 Earnings Conference

Karyopharm Therapeutics Inc (KPTI) Q1 2022

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q1 2022 Earnings Conference

Karyopharm Therapeutics Inc (KPTI) Q4 2021 Earnings Call

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q4 2021 Earnings Conference

Karyopharm Therapeutics Inc (KPTI) Q3 2021 Earnings Conference

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q3 2021 Earnings Conference

Karyopharm Therapeutics Inc (KPTI) Karyopharm to Report Second Quarter 2021 Financial Results on August 5, 2021

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q2 2021 Earnings Conference

Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead

The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While…

Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp — Vice President, Investor and…

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q1 2020 Earnings Call Transcript

Karyopharm Therapeutics Inc (KPTI) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Ian Karp — Vice President, Investor and Public…